Real-time enrollment status for this extensive-stage small-cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:13 PM UTC
| NCT Number | NCT06712355 |
| Recruiting Status | Recruiting |
| Condition | Extensive-stage Small-cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 621 participants |
| Active Locations | 36 sites in the US |
| Sponsor | BioNTech SE |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of August 28, 2026: Clinical trial NCT06712355 is currently recruiting participants. This phase3 study for extensive-stage small-cell lung cancer is actively seeking new participants at 36 locations across the United States. The study is sponsored by BioNTech SE. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06712355 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06712355 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.